Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells

Carcinogenesis

Volumn 33, Issue 12, 2012, Pages 2362-2368

  Baggott, Rhiannon R ^a   Mohamed, Tamer M A ^b,c   Oceandy, Delvac ^b   Holton, Marylouisa ^a,e   Blanc, Marie Cécile ^a   Roux Soro, Sandrine C ^a   Brown, Sarah ^a   Brown, James E ^d   Cartwright, Elizabeth J ^b   Wang, Weiguang ^a   Neyses, Ludwig ^b   Armesilla, Angel L ^a  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Zagazig University   (Egypt)

^d ASTON UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCINEURIN; FAS LIGAND; PACLITAXEL; PLASMA MEMBRANE CALCIUM ADENOSINE TRIPHOSPHATASE 2; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CALCINEURIN; CELL LINE, TUMOR; FAS LIGAND PROTEIN; GENES, P53; HUMANS; NFATC TRANSCRIPTION FACTORS; PACLITAXEL; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84870359517     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs282     Document Type: Article

References (35)

1. Hanahan, D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
2. McConkey, D.J. et al. (1997) The role of calcium in the regulation of apoptosis. Biochem. Biophys. Res. Commun., 239, 357-366.
3. Monteith, G.R. et al. (2007) Calcium and cancer: targeting Ca2+ transport. Nat. Rev. Cancer, 7, 519-530.
4. VanHouten, J. et al. (2010) PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer. Proc. Natl. Acad. Sci. U.S.A., 107, 11405-11410.
5. Strehler, E.E. et al. (2007) Plasma-membrane Ca(2+) pumps: structural diversity as the basis for functional versatility. Biochem. Soc. Trans., 35(Pt 5), 919-922.
6. Holton, M.L. et al. (2010) Plasma membrane calcium ATPase proteins as novel regulators of signal transduction pathways. World J. Biol. Chem., 1, 201-208.
7. Roberts-Thomson, S.J. et al. (2010) Plasma membrane calcium pumps and their emerging roles in cancer. World J. Biol. Chem., 1, 248-253.
8. Buch, M.H. et al. (2005) The sarcolemmal calcium pump inhibits the calcineurin/ nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. J. Biol. Chem., 280, 29479-29487.
9. Holton, M. et al. (2007) The interaction between endogenous calcineurin and the plasma membrane calcium-dependent ATPase is isoform specific in breast cancer cells. FEBS Lett., 581, 4115-4119.
10. Klee, C.B. et al. (1998) Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J. Biol. Chem., 273, 13367-13370.
11. Li, H. et al. (2011) Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol., 21, 91-103.
12. Crabtree, G.R. et al. (2002) NFAT signaling: choreographing the social lives of cells. Cell, 109 Suppl, S67-S79.
13. Jayanthi, S. et al. (2005) Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc. Natl. Acad. Sci. U.S.A., 102, 868-873.
14. Srivastava, R.K. et al. (1999) Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J. Exp. Med., 190, 253-265.
15. Ryeom, S. et al. (2003) The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nat. Immunol., 4, 874-881.
16. Sambrook, J. et al. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Plumb, J.A. et al. (1989) Effects of the pH dependence of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res., 49, 4435-4440.
18. Ehrenschwender, M. et al. (2009) The role of FasL and Fas in health and disease. Adv. Exp. Med. Biol., 647, 64-93.
19. Crown, J. et al. (2000) The taxanes: an update. Lancet 355(9210), 1176-1178.
20. Holton, M. et al. (2010) Endothelial nitric oxide synthase activity is inhibited by the plasma membrane calcium ATPase in human endothelial cells. Cardiovasc. Res., 87, 440-448.
21. Wu, X. et al. (2009) Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents. J. Clin. Invest., 119, 976-985.
22. Kosiorek, M. et al. (2011) Interaction of plasma membrane Ca(2+)-ATPase isoform 4 with calcineurin A: implications for catecholamine secretion by PC12 cells. Biochem. Biophys. Res. Commun., 411, 235-240.
23. Hayashi, H. et al. (2009) Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin. J. Biol. Chem., 284, 29605-29613.
24. Shou, Y. et al. (2004) Calcineurin-mediated Bad translocation regulates cyanide-induced neuronal apoptosis. Biochem. J., 379(Pt 3), 805-813.
25. Almeida, S. et al. (2004) FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures. Neurobiol. Dis., 17, 435-444.
26. Szydlowska, K. et al. (2006) Neuroprotectant FK506 inhibits glutamateinduced apoptosis of astrocytes in vitro and in vivo. J. Neurochem., 99, 965-975.
27. Wang, L. et al. (2011) Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo. Mol. Endocrinol., 25, 1376-1386.
28. Ryeom, S. et al. (2008) Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell, 13, 420-431.
29. Luo, C. et al. (1996) Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import. Proc. Natl. Acad. Sci. U.S.A., 93, 8907-8912.
30. Xue, J. et al. (2011) Calcineurin selectively docks with the dynamin Ixb splice variant to regulate activity-dependent bulk endocytosis. J. Biol. Chem., 286, 30295-30303.
31. Czirják, G. et al. (2006) Targeting of calcineurin to an NFAT-like docking site is required for the calcium-dependent activation of the background K+ channel, TRESK. J. Biol. Chem., 281, 14677-14682.
32. Huovinen, M. et al. (2011) Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis. Toxicol. In Vitro, 25, 1007-1017.
33. van den Berg, H.W. et al. (1990) High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. Br. J. Cancer, 61, 504-507.
34. Runnebaum, I.B. et al. (1991) Mutations in p53 as potential molecular markers for human breast cancer. Proc. Natl. Acad. Sci. U.S.A., 88, 10657-10661.
35. Muscella, A. et al. (2011) The platinum (II) complex [Pt(O, O'-acac) (γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells. Biochem. Pharmacol., 81, 91-103.